iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments

Neil Gallagher M.D., Ph.D., former AbbVie Chief Medical Officer and President of R&D at Syndax, brings considerable experience in oncology drug developmentAnthony Mancini, currently Global Chief Commercial Officer at Revolution Medicines, led several successful oncology product launches at Genmab and BMSView original content:https://www.prnewswire.co.uk/news-releases/ionctura-strengthens-medical-and-commercialization-expertise-with-two-non-executive-board-appointments-302512288.html

@ prnewswire.co.uk

Hol dir den Wissensvorsprung der Profis. Seit 2005 liefert der Börsenbrief trading-notes verlässliche Trading-Empfehlungen – dreimal die Woche, direkt in dein Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt anmelden.